Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma. Li T, Dai Y, Fu X, Cai Q, et al. BMC Cancer 2024;24:1421.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li T, Dai Y, Fu X, Cai Q, et al. Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma. BMC Cancer 2024;24:1421.
PMID: 39558325